HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

P Y Wang Selected Research

Neurofibromatosis 1 (Neurofibromatosis Type I)

4/2000Thalamic involvement in neurofibromatosis type 1: evaluation with proton magnetic resonance spectroscopic imaging.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


P Y Wang Research Topics

Disease

4Neoplasms (Cancer)
01/2022 - 01/2001
3Colorectal Neoplasms (Colorectal Cancer)
11/2021 - 09/2017
2Neoplasm Metastasis (Metastasis)
11/2021 - 01/2021
1Carcinogenesis
01/2022
1Diverticulitis
11/2021
1Hemorrhage
11/2021
1Gestational Diabetes (Gestational Diabetes Mellitus)
06/2021
1Lymphatic Metastasis
05/2020
1Dyslipidemias (Dyslipidemia)
07/2017
1Hypertriglyceridemia
07/2017
1Hypercholesterolemia
07/2017
1Hyperlipidemias (Hyperlipidemia)
07/2017
1Heat Stroke (Heatstroke)
01/2015
1Immune System Diseases (Immune Disorders)
11/2008
1Epilepsy (Aura)
07/2005
1Prostatic Neoplasms (Prostate Cancer)
05/2003
1Hypertrophy
08/2001
1Temporomandibular Joint Disorders (Temporomandibular Joint Disorder)
06/2001
1Esophageal Squamous Cell Carcinoma
01/2001
1Disease Progression
01/2001
1Insulin Resistance
12/2000
1Body Weight (Weight, Body)
12/2000
1Diabetes Mellitus
12/2000
1Glucose Intolerance
12/2000
1Oral Lichen Planus
09/2000
1Neurofibromatosis 1 (Neurofibromatosis Type I)
04/2000
1Hematoma
03/2000
1Cerebral Hemorrhage
03/2000
1Rett Syndrome (Rett's Disorder)
02/2000

Drug/Important Bio-Agent (IBA)

3Protons (Proton)IBA
01/2015 - 03/2000
2Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2001
2N-acetylaspartate (N-acetyl aspartate)IBA
07/2005 - 02/2000
2CreatineIBA
07/2005 - 02/2000
1Messenger RNA (mRNA)IBA
01/2022
1Antisense OligonucleotidesIBA
01/2022
1Protein Isoforms (Isoforms)IBA
01/2022
1Hemostatics (Antihemorrhagics)IBA
11/2021
1Triglycerides (Triacylglycerol)IBA
07/2017
1HDL LipoproteinsIBA
07/2017
1HDL CholesterolIBA
07/2017
1Small Interfering RNA (siRNA)IBA
11/2008
1Phosphocreatine (Neoton)IBA
07/2005
1Estrogens (Estrogen)FDA Link
05/2003
1FatsIBA
05/2003
1Inositol 1,4,5-Trisphosphate Receptors (Inositol Triphosphate Receptor)IBA
08/2001
1Free RadicalsIBA
06/2001
1Indicators and Reagents (Reagents)IBA
01/2001
1AntibodiesIBA
01/2001
1Glucose (Dextrose)FDA LinkGeneric
12/2000
1CarbohydratesIBA
12/2000
1Fatty Acids (Saturated Fatty Acids)IBA
12/2000
1Phosphates (Orthophosphate)IBA
09/2000
1Lactic Acid (Lactate)FDA LinkGeneric
03/2000
1Choline (Choline Chloride)IBA
02/2000

Therapy/Procedure

3Therapeutics
11/2021 - 01/2001
1Drug Therapy (Chemotherapy)
11/2021
1Conservative Treatment
11/2021
1Glycemic Control
06/2021
1Operative Surgical Procedures
05/2020
1Precision Medicine
09/2017
1Gas Lasers
09/2000